Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis.
-
Page/Page column 24-25
(2008/06/13)
More Articles about upstream products of 116882-73-6